Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction

Journal of Nuclear Medicine

Volumn 46, Issue 9, 2005, Pages 1497-1504

  Cot, Albert ^a,b   Falcón, Carles ^a   Crespo, Cristina ^a   Sempau, Josep ^b   Pareto, Deborah ^a   Bullich, Santiago ^a   Lomeña, Francisco ^c,d   Calviño, Francisco ^b   Pavía, Javier ^c,d   Ros, Domènec ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Dopamine transporter; Fully 3D reconstruction; Monte Carlo methods; Scatter correction

Indexed keywords

DOPAMINE TRANSPORTER; TECHNETIUM 99M; CARRIER PROTEIN; DIAGNOSTIC AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOPHARMACEUTICAL AGENT; SLC6A3 PROTEIN, HUMAN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ARTICLE; DOPAMINERGIC TRANSMISSION; EARLY DIAGNOSIS; IMAGE RECONSTRUCTION; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION SCATTERING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; ALGORITHM; BRAIN MAPPING; COMPUTER ASSISTED DIAGNOSIS; CORPUS STRIATUM; EVALUATION; HUMAN; IMAGE QUALITY; INSTRUMENTATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; SCINTISCANNING; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION;

ALGORITHMS; BRAIN MAPPING; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; SCATTERING, RADIATION; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 27744538710     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Verhoeff NP. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorder. Psychopharmacology. 1999;147:217-249.
2. Dodel RC, Höffken H, Carsten Möller J, et ai. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach. Mov Disord. 2003;18(suppl S7):S52-S62.
3. Tatsch K. Imaging of the dopaminergic system in parkinsonism with SPET. Nucl Med Commun. 2001;22:819-827.
4. Pilowsky LS. Probing targets for antipsychotic drug with PET and SPET receptor imaging. Nucl Med Commun. 2001;22:829-833.
5. Piccini PP. Dopamine transporter: basic aspects and neuroimaging. Mov Disord. 2003;18(suppl S7):S3-S8.
6. Poewe W, Scherfler C. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice. Mov Disord. 2003;18(suppl S7):S16-S21.
7. Kung MP, Stevenson DA, Plössl K, et al. [99m-Tc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med. 1997;29:372-380.
8. 123I]EP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62:133-140.
9. Stoof JC, Winogrodzka A, van Muiswinkel FL, et al. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy. Eur J Pharmacol. 1999;30:75-86.
10. Seibyl JP, Marek K, Sheff K, et al. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients. J Nucl Med. 1997;38:1453-1459.
11. Soret M, Koulibaly PM, Darcourt J, Hapdey S, Buvat I. Quantitative accuracy of dopaminergic neurotransmission imaging with 123-I SPECT. Eur J Nucl Med Mol Imaging. 2003;44:1184-1193.
12. 99mTc brain SPECT. J Nucl Med. 2001;42:300-308.
13. Pareto D, Cot A, Pavia J, et al. Iterative reconstruction with compensation of the spatial valiant fan beam collimator response in neuro transmission SPET imaging. Eur J Nucl Med Mol Imaging. 2003;30:1322-1329.
14. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601-609.
15. Buvat I, Rodriguez-Villafuerte M, Todd-Pokropek A, Benali H, Di Paola R. Comparative assessment of nine scatter correction methods based on spectral analysis using Monte Carlo simulations. J Nucl Med. 1995;36:1476-1496.
16. Zaidi H, Koral KF. Scatter modelling and compensation in emission tomography. Eur J Nucl Med Mol Imaging. 2004;31:761-782.
17. Jaszczak RJ, Greer KL, Floyd CE, Harris CC, Coleman RE. Improved SPECT quantification using compensation for scattered photons. J Nucl Med. 1984;25:893-900.
18. Ogawa K, Harata Y, Ichihara T, Kubo A, Hashimoto S. A practical method for position-dependent Compton-scatter correction in SPECT. IEEE Trans Med Imaging. 1991;10:408-412.
19. Axelsson B, Msaki P, Israelsson A. Subtraction of Compton-scattered photons in single-photon emission computerized tomography. J Nucl Med. 1984;25:490-494.
20. Kim KM, Watabe H, Shidahara M, Ishida Y, Iida H. SPECT collimator dependency of scatter and validation of transmission-dependent scatter compensation methodologies. IEEE Trans Nucl Sci. 2001;48:689-696.
21. Floyd CE, Jaszczak RJ, Greer KL, Coleman RE. Inverse Monte Carlo as an unified reconstruction algorithm for ECT. J Nucl Med. 1986;27:1577-1585.
22. Lazaro D, Breton V, Buvat I. Feasibility and value of fully 3D Monte Carlo reconstruction in single-photon emission computed tomography. Nucl Instrum Methods Phys Res A. 2004;527:195-200.
23. Beekman FJ, Kamphuis C, Frey EC. Scatter compensation methods in 3D iterative SPECT reconstruction: a simulation study. Phys Med Biol. 1997;42:1619-1632.
24. Beekman FJ, de Jong HWAM, Geloven S. Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation. IEEE Trans Med Imaging. 2002;21:867-877.
25. Bowsher JE, Johnson VE, Turkmgton TG, Jaszczak RJ, Floyd CE, Coleman RE. Bayesian reconstruction and use of anatomical a priori information for emission tomography. IEEE Trans Med Imaging. 1996;15:673-686.
26. Hoehn HM, Yahr MD. Parkmsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
27. 99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med. 2000;41:584-589.
28. 99mTc- TRODAT-1 SPET for the evaluation of Parkinson's disease. Eur J Nucl Med Mol Imaging. 2004;31:155-161.
29. Haynor DR, Harrison RL, Lewellen TK. The use of importance sampling techniques to improve the efficiency of photon tracking in emission tomography simulations. Med Phys. 1991;18:990-1001.
30. Zaidi H. Comparative evaluation of photon cross-section libraries for materials of interest in PET Monte Carlo simulations. IEEE Trans Nucl Sci. 2000;47:2722-2734.
31. Cot A, Sempau J, Pareto D, et al. Evaluation of the geometric, scatter, and septal penetration components in fan-beam collimators using Monte Carlo simulation. IEEE Trans Nucl Sci. 2002;49:12-16.
32. Falcón C. Iterative reconstruction algorithms in SPECT [in Spanish] [PhD thesis]. Barcelona, Spain: Universitat de Barcelona; 1999.
33. Brozolo G, Vitaletti M. Conjugate gradient subroutines for the IBM 3090 Vector Facility. IBM J Res Dev. 1989;33:125-135.
34. Cot A, Falcón C, Pavía J, Calviño F, Ros D. Evaluation of scattering models in brain SPECT imaging. IEEE Nucl Sci Symp Conf Rec. 2003;4:2901-2904.
35. Dobbeleir AA, Hambÿe AE, Franken PR. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with iodine-123 labelled compounds in clinical practice. Eur J Nucl Med. 1999;26:655-658.
36. 123I SPECT imaging using Monte Carlo simulation. Phys Med Biol. 2004;49:3125-3136.